Quoted Micro 15 June 2026

AQUIS STOCK EXCHANGE Sterling Digital (ASIC) has entered a gas purchase agreement with a US supplier to power the Bitcoin mining operations in West Texas. The agreement lasts five years and includes the rights over 1.5 acres of land to establish the Bitcoin mining site. There is a minimum buying commitment of 96,360MMBtu of gas […]

Quoted Micro 27 April 2026

AQUIS STOCK EXCHANGE Silverwood Brands (SLWD) has published delayed results for the 18 months to June 2025. There were delays in consolidating the Japanese subsidiary accounts and the company intends to improve its financial reporting capability. Full year revenues were £23.9m and the reported loss was £18.3m. That was predominantly down to impairment charges. Cash […]

Quoted Micro 13 April 2026

AQUIS STOCK EXCHANGE Oscillate (SRVL), which is changing its name to Serval Resources, raised £34,000 in its retail offer at 22.5p/share, which is below the maximum level of £300,000. It is acquiring Kalahari Copper and moving to AIM on 27 April. Digital assets investor Valereum (VLRM) has received confirmation that the $300,000 cash element of […]

Quoted Micro 29 July 2024

AQUIS STOCK EXCHANGE Good Life Plus (GDLF) reported its figures for the 16 months to January 2024. This includes a full contribution from the core luxury prize draw business and a few months of the shell it reversed into. Revenues were £2.39m and the loss was £3.98m, although that included costs of the reversal. The […]

Quoted Micro 9 May 2022

AQUIS STOCK EXCHANGE In 2021, Newbury Racecourse (NYR) is paying a special dividend of 89.6p a share. The £3m payment comes after the receipt of the final £10.7m from the sale of housing development land. Newbury Racecourse increased turnover by 75% to £14.8m as racing returned to the course. There is still potential for further […]

Andrew Hore – Quoted Micro 3 January 2022

AQUIS STOCK EXCHANGE Valereum Blockchain (VLRM) is planning to acquire trust management and funds administration company Juno Group. The Gibraltar-based company will cost £850,000 in cash and shares. Chana Greenberg is no longer chief executive of Pharma C Investments (PCIL) and Tony Shilito will be acting chief executive. Walls and Futures REIT (WAFR) reported a […]